Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Eleni Res"'
Autor:
Foteinos-Ioannis Dimitrakopoulos, Anna Goussia, Georgia-Angeliki Koliou, Katerina Dadouli, Anna Batistatou, Helen P. Kourea, Mattheos Bobos, Petroula Arapantoni-Dadioti, Olympia Tzaida, Triantafyllia Koletsa, Sofia Chrisafi, Maria Sotiropoulou, Alexandra Papoudou-Bai, Irene Nicolaou, Antonia Charchanti, Davide Mauri, Gerasimos Aravantinos, Ioannis Binas, Eleni Res, Amanda Psyrri, Dimitrios Pectasides, Dimitrios Bafaloukos, Anna Koumarianou, Iliada Bompolaki, Georgios Rigakos, Charisios Karanikiotis, Angelos Koutras, Flora Zagouri, Helen Gogas, George Fountzilas
Publikováno v:
Breast, Vol 73, Iss , Pp 103668- (2024)
Background: Dose-dense sequential (dds) chemotherapy has changed the clinical outcome of patients with early breast cancer (BC). To investigate the impact of dose intensity (DI) in the adjuvant setting of BC, this observational trial (HE 10/10) was c
Externí odkaz:
https://doaj.org/article/c87747da75374992ae057d95eb9eb69d
Autor:
Anna Koumarianou, Anastasios Ntavatzikos, David Symeonidis, Christos Vallilas, Maria Giannakakou, Georgios Papaxoinis, Spyridon Xynogalos, Ioannis Boukovinas, Stamatina Demiri, Katerina Kampoli, Georgios Oikonomopoulos, Epaminontas Samantas, Eleni Res, Nikolaos Androulakis, Georgia Vourli, Ioannis Souglakos, Michalis Karamouzis
Publikováno v:
Biomedicines, Vol 11, Iss 5, p 1267 (2023)
Background: Trifluridine/tipiracil (FTD/TPI) is an oral antimetabolite agent comprised of trifluridine, a thymidine-based nucleoside analogue that inhibits cell proliferation following its incorporation into DNA, and tipiracil that helps maintain the
Externí odkaz:
https://doaj.org/article/127365e0afa7497098993b8317173877
Autor:
Foteinos-Ioannis Dimitrakopoulos, Kyriaki Papadopoulou, Dimitrios Pectasides, Anna Batistatou, Kitty Pavlakis, George Fountzilas, Helen P. Kourea, Sofia Chrisafi, George Pentheroudakis, Vassiliki Kotoula, Pavlos Papakostas, Eleni Galani, Eleni Res, Dimitrios Bafaloukos, Angelos Koutras, Georgia-Angeliki Koliou, Mattheos Bobos, Kyriakos Chatzopoulos, Anthoula Asimaki-Vlachopoulou
Publikováno v:
Cancer Research and Treatment. 54:1053-1064
Purpose Angiogenesis is a crucial phenomenon in the development and progression of breast cancer (BC), but the clinical significance of angiogenesis-related proteins in metastatic BC remains unknown. This study investigates the prognostic value of va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63597cddc6239b15370171a50afaafc8
https://doi.org/10.4143/crt.2021.748
https://doi.org/10.4143/crt.2021.748
Autor:
Flora Zagouri, Georgia-Angeliki Koliou, Foteinos Dimitrakopoulos, Christos Papadimitriou, Ioannis Binas, Angelos Koutras, Pavlos Papakostas, Christos Markopoulos, Vasileios Venizelos, Grigorios Xepapadakis, Charisios Karanikiotis, Amanda Psyrri, Dimitrios Bafaloukos, Paris Kosmidis, Gerasimos Aravantinos, Eleni Res, Davide Mauri, Anna Koumarianou, Kalliopi Petraki, Anna Tsipoura, Dimitrios Pectasides, Helen Gogas, George Fountzilas
Publikováno v:
Cancer Research. 82:P1-12
Background: Dose-dense sequential chemotherapy based on anthracyclines and taxanes has achieved an 18% reduction of recurrence risk in the adjuvant setting of early breast cancer (BC). However, the optimal chemotherapy schedule and the preferable int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1bb7d635a4d6ae5064febdbd6f681679
https://doi.org/10.1158/1538-7445.sabcs21-p1-12-01
https://doi.org/10.1158/1538-7445.sabcs21-p1-12-01
Autor:
Dimitrios Bafaloukos Snr, Athina Christopoulou, Anastasios Boutis, Gerasimos Aravantinos, Georgia-Angeliki Koliou, Sofia Lampaki, Helena Linardou, George Fountzilas, Panagiotis Papantoniou, Efthalia Lalla, Eleni Res, Nicoleta Pastelli, Margarita-Ioanna Koufaki, Georgios Rigakos, Pavlos Papakotoulas, Giannis Mountzios, Dionisios Spyratos, Anna Koumarianou, Anastasios Grivas, Athanassios Vozikis, Georgios Oikonomopoulos, Ioannis Kontogiorgos
Publikováno v:
Lung Cancer: Targets and Therapy
Lung Cancer: Targets and Therapy, Vol Volume 12, Pp 93-102 (2021)
Lung Cancer: Targets and Therapy, Vol Volume 12, Pp 93-102 (2021)
Giannis Mountzios,1 Sofia Lampaki,2 Georgia-Angeliki Koliou,3 Athanassios Vozikis,4 Ioannis Kontogiorgos,4 Panagiotis Papantoniou,4 Margarita-Ioanna Koufaki,4 Eleni Res,5 Anastasios Boutis,6 Athina Christopoulou,7 Nicoleta Pastelli,8 Anastasios Griva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eaae6c4e1bec22d7a5f9e1d4ebb24e49
http://europepmc.org/articles/PMC8415762
http://europepmc.org/articles/PMC8415762
Autor:
Flora Zagouri, Georgia-Angeliki Koliou, Foteinos Dimitrakopoulos, Christos Papadimitriou, Ioannis Binas, Angelos Koutras, Pavlos Papakostas, Christos Markopoulos, Vasileios Venizelos, Grigorios Xepapadakis, Αngeliki Andrikopoulou, Charisios Karanikiotis, Amanda Psyrri, Dimitrios Bafaloukos, Paris Kosmidis, Gerasimos Aravantinos, Eleni Res, Davide Mauri, Anna Koumarianou, Kalliopi Petraki, Anna Tsipoura, Dimitrios Pectasides, Helen Gogas, George Fountzilas
Publikováno v:
Br J Cancer
BACKGROUND: Dose-dense sequential chemotherapy with anthracyclines and taxanes achieved an 18% reduction of recurrence risk in early breast cancer (BC). The optimal chemotherapy schedule and interval between cycles remain under investigation. METHODS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71d12c3b75e98f52121a3ff58e187863
https://europepmc.org/articles/PMC9381581/
https://europepmc.org/articles/PMC9381581/
Autor:
Amanda Psyrri, Georgios Lazaridis, Georgia-Angeliki Koliou, Evangelia Razis, Georgios Koumakis, George Fountzilas, Flora Zagouri, Meletios A. Dimopoulos, Nikolaos K. Kentepozidis, D. Tryfonopoulos, Angelos Koutras, Ioannis Chryssogonidis, Haralabos P. Kalofonos, Eleni Res, Athanasios Kotsakis, Elizabeth Psoma
Publikováno v:
British Journal of Cancer
Background Cabazitaxel is a novel taxane that might be active in breast cancer resistant to first-generation taxanes. Methods The purpose of the current multicentre phase II trial was to evaluate the activity and safety of cabazitaxel, as second-line
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8da43f0e499903f9ea7ca5c104631c76
https://doi.org/10.1038/s41416-020-0909-4
https://doi.org/10.1038/s41416-020-0909-4
Autor:
Evangelia Moirogiorgou, Eleni Res, Christos Christodoulou, D. Tryfonopoulos, I. Binas, Mattheos Bobos, Kyriakos Chatzopoulos, Dimitrios Bafaloukos, Amanda Psyrri, Irene Nicolaou, George Pentheroudakis, Christina Magkou, Kyriaki Papadopoulou, Vassiliki Rapti, Dimitrios Pectasides, George Fountzilas, Sofia Chrisafi, Athanasios Alexopoulos, Maria Sotiropoulou, Pavlos Papakostas, Athanasios Kotsakis, Angelos Koutras, Vassiliki Kotoula, Georgia-Angeliki Koliou, Evangelia Razis
Publikováno v:
Oncol Lett
Prognostic and predictive biomarkers are being studied for the diagnosis and treatment of breast cancer. The present study retrospectively assessed the mRNA expression of HER family receptor ligands and of other potential prognostic biomarkers and th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10d09e2e4dee013d0c264f3a5dc170b6
https://doi.org/10.3892/ol.2021.13141
https://doi.org/10.3892/ol.2021.13141
Autor:
George Saroglou, George Fountzilas, Nikolaos Spanakis, Sofia Lampaki, Elena Fountzilas, Sofia Karageorgopoulou, Eleni Res, Nikolaos Tsoukalas, Nephely Alevra, Anastasios Vagionas, Dimitra Chatzokou, Athina Christopoulou, Zacharenia Saridaki, Helena Linardou, Stavroula Sgourou, Giannis Mountzios, Joseph Sgouros, Georgia-Angeliki Koliou, Evangelia Razis
Publikováno v:
Cancers
Volume 13
Issue 18
Cancers, Vol 13, Iss 4621, p 4621 (2021)
Volume 13
Issue 18
Cancers, Vol 13, Iss 4621, p 4621 (2021)
Data on the effectiveness and safety of approved SARS-CoV-2 vaccines in cancer patients are limited. This observational, prospective cohort study investigated the humoral immune response to SARS-CoV-2 vaccination in 232 cancer patients from 12 HeCOG-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7d0b2f810844b263517a5a7df4ecb88
Autor:
Nikolaos Spathas, Anna C. Goussia, Georgia-Angeliki Koliou, Helen Gogas, Flora Zagouri, Anna Batistatou, Antonia V. Charchanti, Alexandra Papoudou-Bai, Mattheos Bobos, Sofia Chrisafi, Kyriakos Chatzopoulos, Ioannis Kostopoulos, Triantafyllia Koletsa, Petroula Arapantoni, Dimitrios Pectasides, Eleni Galani, Angelos Koutras, George Zarkavelis, Emmanouil Saloustros, Dimitrios Bafaloukos, Charisios Karanikiotis, Iliada Bompolaki, Gerasimos Aravantinos, Amanda Psyrri, Evangelia Razis, Anna Koumarianou, Eleni Res, Helena Linardou, George Fountzilas
Publikováno v:
Cancers; Volume 14; Issue 22; Pages: 5635
Tumor-infiltrating lymphocytes (TILs) contribute to breast cancer (BC) prognosis. We investigated the prognostic impact of CD8+ TILs in patients with early breast cancer treated with adjuvant chemotherapy in a large observational clinical trial. Alon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e93c3efd7fb87c6ef0be1fd3e99b10d0
https://doi.org/10.3390/cancers14225635
https://doi.org/10.3390/cancers14225635